INSIGHTS ON LIQUID DOSE MANUFACTURING
-
CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever
As demand for GLP-1s and biologics accelerates and timelines compress, it's become more crucial that pharmaceutical companies stay competitive and bring therapies to market faster by partnering with a CDMO.
-
Cost-Effective Strategies For Sterile Injectable Outsourcing
Explore how CMOs are playing a pivotal role in enabling pharmaceutical companies to optimize their operations and how this collaboration is reshaping the future of pharmaceutical manufacturing.
-
Expanding The Viscosity Limits Of Peristaltic Dosing
Discover how innovations in closed-loop control and mechanical design extend peristaltic dosing limits to 2000 cP, maintaining accuracy while preserving the advantages of sterile, disposable paths.
-
Pioneering Precision In Pharma And Radiopharma Solutions
Discover a company that delivers innovative pharmaceutical production solutions and specializes in Radiopharmaceuticals, Cell and Gene Therapy, and traditional drugs with precision-engineered, integrated systems.
-
Engineering Challenges Of Designing Pharmaceutical Isolators3/27/2025
Designing pharmaceutical isolators requires navigating complex engineering hurdles, from ensuring chemical compatibility to optimizing airflow and pressure. Explore the critical considerations that guarantee drug manufacturing safety and efficiency.
-
Alba® Syringe Platform: Ensuring Stability For Sensitive Drugs1/13/2025
Check out this exciting video showcasing the key advantages of Alba®: innovative coating technology that reduces potential interaction between the drug and container surface.
-
Empowering Innovation: Harnessing CDMO Potential For Sterile Injectables10/20/2025
Specialized CDMOs are essential for meeting the growing demand and complex quality requirements for sterile injectables. Outsourcing provides crucial benefits like cost savings, flexibility, and a strategic focus on core competencies.
-
Challenges And Solutions In Lyophilization Development For ADCs12/10/2025
Successful ADC lyophilization requires a robust, individualized process driven by thermal characterization using DSC and FDM to define the critical parameters for stability and efficient manufacturing.
-
Optimizing Pharmaceutical Isolator Design3/22/2024
Explore the importance of isolators in the pharmaceutical and biotech industries, the challenges of innovating aseptic isolator design, best practices, and key aspects of design optimization.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Cell and gene therapies have increased in popularity in recent years, and thanks to their ability to provide one-time treatments these therapies will play a significant role in treating some of the world's most challenging diseases. These drug products treat patients afflicted with genetic disorders and cancers by targeting the source of disease and altering its genetic makeup to eliminate its cause or symptoms. These therapies are expensive and complex and have been proven effective in numerous cases, but they present a challenge in producing them at scale and at a reasonable cost.
-
Opportunities for improving and streamlining the media fill process are interesting for aseptic filling operations. In particular, the manual visual inspection process used to inspect media vials for signs of contamination after incubation is considered to be tedious and time-consuming.
-
Used 300 sq ft BOC Edward freeze dryer, model LYOMAX 28, 316L stainless steel product contact surfaces with (13) 1170 mm wide x 1850 mm deep usable shelves, 115 mm shelf spacing, stoppering, external condenser with 300 kg ice capacity, refrigeration and vacuum skid with liquid natural gas refrigeration, model AV-LUS BOC Edward loading / unloading skid, 480 volt with controls, freeze dryer serial# MTE1930, built 2004.
-
The MicroSphere is a clean, cost-effective C.A.I for sterile compounding, that is USP <797> compliant.
-
ASEPTiCell is integrated with isolator-barrier technologies to fully enclose and tightly control the aseptic environment for ideal conditions for processing sterile drug products. The system can be configured with a Restricted Access Barrier System (RABS) or an aseptic isolator to provide uninterrupted aseptic conditions during production. With isolator integrated systems, the ASEPTiCell is completely compatible with repeated in-situ bio-decontamination using hydrogen peroxide to further enhance the sterility assurance of the system.